The benefit of recanalization in basilar artery occlusion (BAO) has been established. The baseline extent of brain stem damage may also influence the outcome. We investigated whether a baseline diffusion-weighted imaging (DWI) score may provide additional prognostic value in BAO.
A cute basilar artery occlusion (BAO) is a devastating disease, 1 with mortality reaching 80%-90% in patients without recanalization. 2, 3 Acute BAO accounts for 6%-10% of stroke in trials of intracranial large-vessel occlusion. 4, 5 Intraarterial thrombolysis (IAT) and percutaneous transluminal angioplasty/stent placement have decreased BAO mortality to 30%-65%. [6] [7] [8] [9] [10] [11] [12] Fewer data are available for intravenous thrombolysis (IVT), [13] [14] [15] but a recent meta-analysis showed no significant difference in outcome between IVT and IAT, despite higher recanalization rates with IAT. 11 To our knowledge, no randomized study comparing IVT and IAT is available.
Early recanalization is the best documented predictor of good outcome in BAO. Baseline ischemic damage may also influence the prognosis because an extensive brain stem lesion may diminish the benefits of recanalization. The prognostic value of DWI and perfusion-weighted imaging (PWI) has been demonstrated in patients with acute anterior ischemic stroke. Patients with an adequate DWI-PWI mismatch benefited from reperfusion, whereas those without a PWI-DWI mismatch showed no benefit from therapy. 16 Moreover, patients with a large PWI and/or DWI lesion, with or without a PWI-DWI mismatch, appeared at higher risk of intracranial hemorrhage after IVT. 16 Multitechnique MR imaging has also been used in posterior circulation stroke, [17] [18] [19] [20] but no prospective series has validated its predictive value. Acute global DWI lesion volume did not correlate with the baseline National Institutes of Health Stroke Scale (NIHSS) score in previous studies of vertebrobasilar ischemic stroke. 19, 21 A score based on arterial territory segmentation may be more appropriate. We assessed the prognostic impact of baseline brain stem DWI scores in consecutive patients treated with endovascular therapy for acute BAO.
Materials and Methods

Patients
From November 2003 to June 2007, consecutive patients who underwent MR imaging before treatment with endovascular procedures for acute BAO were included in the present study. Inclusion criteria were the following: 1) brain stem or cerebellar symptoms with onset within 48 hours before treatment; 2) MR imaging including DWI and MR angiography completed before treatment; and 3) BAO confirmed by intra-arterial digital substraction angiography (DSA) and treated by endovascular approaches. Exclusion criteria included the following: 1) evidence of any intracranial hemorrhage on pretreatment MR imaging, and 2) clinical or laboratory contraindication for IAT. Informed consent was obtained from the patient or relatives before treatment. During the study period, 37 consecutive patients underwent endovascular therapy for vertebrobasilar stroke. Among these, 2 patients had a P1 occlusion without BAO and were excluded. Among the remaining 35 patients, 6 had a CT scan instead of MR imaging (agitated or hemodynamically unstable, n ϭ 4; unavailable MR imaging, n ϭ 2). Twenty-nine patients were eventually included.
Baseline NIHSS score and Glasgow Coma Scale (GCS) were assessed by a trained stroke neurologist on admission. Age, pretreatment duration of coma, and time from symptom onset to treatment were recorded. Clinical outcome was assessed by the modified Rankin Scale (mRS) at 3 months and dichotomized as favorable (mRS, 0 -2) or unfavorable (mRS, [3] [4] [5] [6] . Symptomatic intracranial hemorrhage (SIH) was defined as a neurologic deterioration (Ն4 points in the NIHSS) associated with intracranial bleeding on control CT. 3) 3D time-of-flight angiography (without gadolinium): TR, 25 ms; TE, 3.1 ms; section thickness, 0.5 mm; 140 sections; FOV, 160 mm; scan matrix, 360; reconstruction matrix, 512; imaging time, 4 minutes 14 seconds.
Imaging Protocol
Selective diagnostic 4-vessel DSA was performed in all cases. Thrombolysis in Myocardial Infarction (TIMI) grades were used to assess recanalization of the basilar artery. TIMI grades 0 -1 were classified as recanalization failure and TIMI grades 2-3 defined successful recanalization. CT was performed on days 1 and 7 to rule out bleeding.
Image Analysis: DWI Lesion Scoring
A semiquantitative scale was used to evaluate the extent of the brain stem DWI lesion on pretreatment MR imaging according to the arterial territories of the medulla, pons, and midbrain as described by Tatu et al (Fig 1) . 22 The number of arterial territories with abnormal DWI was assessed at each brain stem level: 0 -8 in the medulla, 0 -6 in the pons, and 0 -8 in the midbrain. The total number of involved arterial territories defined the brain stem DWI lesion score, comprising scores between 0 and 22. Cerebellar DWI lesions were dichotomized as minor (less than one third of a cerebellar hemisphere) or major (more than one third of a cerebellar hemisphere). MR imaging analysis was done by 2 experienced observers blinded to the severity of the clinical deficit. The interobserver and intraobserver variations were assessed by comparing the differences in measurement 10 days apart on the whole sample. For the discrepant cases, the final scoring of DWI data was achieved by a consensual analysis.
Therapeutic Regimen
Treatment of acute BAO involved several methods with time, reflecting the development of new strategies and the degree of early response to the initial recanalization procedures. We used the following intraarterial treatment regimens: 1) tissue plasminogen activator (tPA) alone (n ϭ 5; mean dosage, 34 Ϯ 11 mg), 2) tPA with intravenous abciximab (n ϭ 4; mean tPA dosage, 30 Ϯ 12 mg; mean abciximab dosage, 23 Ϯ 6 mg), 3) tPA with a mechanical procedure (angioplasty, thromboaspiration, snare microcatheter, n ϭ 16; mean tPA dosage, 30 Ϯ 16 mg), or 4) mechanical procedure only (n ϭ 4). Patients were transferred to the neurologic intensive care unit following the procedure. Prophylactic anticoagulation was started 24 hours after IAT and consisted of enoxaparin (4000 IU/day) and acetylsalicylic acid (100 -300 mg/day) or clopidogrel (75 mg/day). Unfractionated heparin was administered in patients with documented atrial fibrillation.
Statistical Analysis
Descriptive statistics of clinical and DWI parameters are given as median values with ranges, unless indicated otherwise. Spearman rank correlation tests assessed the correlation between DWI parameters and clinical variables. The relationship between SIH and baseline variables (DWI data, NIHSS score, time to treatment) was assessed with Wilcoxon rank sum and Fisher exact tests. Univariate and multivariate logistic regression analyses were used to identify DWI and clinical parameters most closely associated with the final mRS score.
The following explanatory variables were systematically assessed by univariate logistic regression analysis: age, NIHSS score, GCS score, presence or absence of coma (GCS score, Ͻ8), duration of coma before treatment, time to treatment, brain stem DWI lesion score, presence or absence of minor/major cerebellar lesions, and recanalization. Relevant univariate factors (P Ͻ .05) were included in the multivariate analysis, by using a backward stepwise method. Statistical analyses were performed with the Statistical Package for the Social Sciences (Version 11.5 for Windows; SPSS, Chicago, Ill). 
Results
Baseline Clinical and DWI Data
Twenty-nine patients with acute BAO (13 women, 16 men) met study criteria. Their median age was 60 years (range, 26 -77 years). Median NIHSS score was 22 (range, 4 -34). Coma was present in 13/29 (45%) patients, with a median duration of coma before treatment of 6.4 hours (range, 2-18 hours). Median brain stem DWI score was 3 (range, 0 -14). The intraobserver and interobserver reliabilities in measured brain stem DWI lesion scores were r Ͼ 0.9. Major cerebellar DWI lesions were observed in 12/29 (41.4%). Clinical, vascular, DWI data, and outcome are summarized in the on-line Table. Illustrative cases are given in Figs 2 and 3.
Recanalization Rate, Clinical Outcome, and Bleeding Complications
The sites of basilar occlusion were as follows: lower basilar, n ϭ 18; midbasilar, n ϭ 5; upper basilar arteries, n ϭ 6. Median time to treatment was 7.5 hours (range, 3.2-26.6 hours). There was no significant difference in the mean time to treatment between patients with favorable versus unfavorable outcomes: 7.6 Ϯ 3.9 hours versus 9.4 Ϯ 5.5 hours (P ϭ .41). Recanalization was achieved in 22/29 (76%) patients. Lower basilar occlusion was recanalized significantly less often (P ϭ .018). Mean time to treatment showed no significant difference among patients with successful or failed recanalization (9 Ϯ 5.5 hours versus 8.5 Ϯ 4.3 hours, respectively, P ϭ .959). A favorable outcome (mRS, 0 -2) was observed in 8/22 recanalized patients versus 0/7 patients (2 patients were locked in; 5 died) without recanalization (P ϭ .142). Overall mortality was 14/29 patients (48%). Death related to SIH occurred in 5 patients. SIH showed no significant association with the brain stem DWI score (P ϭ .449, Wilcoxon rank sum test), cerebellar damage (P ϭ .622, Fisher exact test), NIHSS score (P ϭ .298, Wilcoxon rank sum test), or time to treatment (P ϭ .204, Wilcoxon rank sum test). No systemic hemorrhagic complication was observed.
Correlation between DWI Scoring and Clinical Variables
The brain stem DWI lesion score was correlated with the baseline NIHSS score and with the presence and length of coma before treatment (r ϭ 0.67, 0.49, and 0.53, respectively; P Ͻ .01). No significant correlation was found between the brain stem DWI lesion score and the recanalization rate or time to treatment.
Baseline Predictors
Univariate analysis showed that a higher baseline NIHSS score (P ϭ .02), a higher brain stem DWI lesion score (P ϭ .03), a lower GCS score (P ϭ .04), and the presence of coma (P ϭ .05) were significantly associated with an unfavorable outcome (Table 1) . Conversely, age, length of coma, time to treatment, cerebellar damage, and recanalization did not correlate with clinical outcome in univariate regression analysis. Significant variables in univariate analyses were included in the multivariate model (NIHSS score, brain stem DWI score, GCS score, and coma on admission). The multivariate analysis showed that the brain stem DWI lesion score was the only independent baseline predictor for clinical outcome ( Table 2 , P ϭ .026).
Discussion
The present study reports the largest baseline DWI data available in acute BAO. The extent of the brain stem DWI lesion was assessed by using a simple and reliable scoring system without additional time-consuming postprocessing. Multivariate regression analysis showed that the extent of the pretreatment brain stem DWI lesion was the strongest baseline predictor of outcome. A study of 10 patients with BAO failed to show a significant relationship between baseline DWI lesion volume and NIHSS score. 19 In contrast, we found a significant association between the brain stem DWI lesion score and the NIHSS score. This discrepancy might be explained by a scoring system based on arterial segmentation rather than a global volume assessment. Indeed, clinical severity and outcome in BAO are likely influenced by strategic brain stem damage (Figs 2 and 3) . The correlation between brain stem DWI score and coma duration may also support this view. A recent study by Renard et al 23 used a 10-point semiquantitative scoring of baseline DWI in 16 patients with acute BAO: 1 point was given for each half of the medulla, pons, and midbrain. Their score included thalamic and temporo-occipital lesions (0.5 point for each structure) as well as cerebellar damage (1 point for unilateral and 2 for bilateral lesions). A total score of Ͼ3 was associated with poor outcome (mRS, Ն3) in univariate analysis. The sample size precluded a multivariate analysis. Both studies support the use of a sectorial scoring of DWI lesions in BAO rather than a volume measurement. A score based on arterial territory segmentation was preferred in the present study. We showed, in addition, that baseline brain stem damage was an independent predictor of outcome.
Formerly described clinical predictors were confirmed: Higher baseline NIHSS score and presence of coma were predictive of poor outcome. 7, 10 Recanalization was achieved in 22/29 (76%) patients, in line with previous studies using interventional approaches. [7] [8] [9] [10] 12 Although no significant association between recanalization and outcome was observed in our series, probably due to the small sample size, no patient with failed recanalization achieved functional independence.
Time to treatment was correlated with neither the brain stem DWI score nor outcome. Our sample size and the proportion of "progressive" strokes in our series (41%) may explain these results. The occlusion level and degree of collateral circulation likely account for the wide spectrum of clinical presentations in BAO. The prognosis of patients with early severe symptoms may be more time-dependent than those with a more protracted evolution.
Our results may have significant implications in acute BAO management. Treatment strategies show great variations in different hospitals regarding the method (intra-arterial versus intravenous procedures) and time window for eligibility. Al- though recanalization may favor partial reversibility of the DWI anomaly, 24 the baseline brain stem DWI score may help to identify patients most likely to benefit from treatment. Extensive brain stem damage may indicate poor prognosis regardless of recanalization success or failure (Fig 3) . Conversely, patients with limited DWI lesions might benefit from late reperfusion therapy (Fig 2) . Nevertheless, clinical implementation of the brain stem DWI score will require further validation with prospective studies. DWI data need to be interpreted together with clinical parameters. Treatment should not be denied on the sole basis of MR imaging results. Accordingly, in this consecutive patient series, no one was denied a recanalization attempt after MR imaging. Patients with limited or extensive brain stem damage were treated both early and late after symptom onset.
Study Limitations
As in most studies of acute BAO, the sample size is the main limitation. More prospective data are needed to delineate the prognostic role of acute DWI in BAO. Lack of uniformity in the treatment regimen may have affected the correlation between the DWI lesion score and outcome, because varying therapies could yield different recanalization rates and outcomes. The different treatment-regimen efficacy could not be assessed in our study due to the limited sample size. Nevertheless, because recanalization and brain stem DWI scores showed no significant correlation, it seems unlikely that the treatment regimen influenced the correlation between DWI score and outcome.
Conclusions
We showed that the brain stem DWI score is an independent baseline predictor of outcome in acute BAO, without correlation to recanalization. In light of previous data, the present study suggests that both pretreatment brain stem damage and reperfusion are major independent determinants of clinical outcome. A DWI score based on arterial territory segmentation appears more appropriate than volume measurements in BAO. Further prospective validation is needed before its use in treatment decisions.
